TOKYO, Jan 18, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today the presentation of research across various types of gastrointestinal cancers during the 2023 American Society […]
LONDON AND HONG KONG, Jan 11, 2023 – (ACN Newswire via SEAPRWire.com) – Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced that ACT Genomics, […]
Bozeman, MT, December 29, 2022 – (SEAPRWire) – Alercell is all set to launch LENA Q51(R) in January 2023. A leukemia diagnostic test based on sequencing DNA will detect up to 51 Genes mutations […]
HONG KONG, Dec 16, 2022 – (ACN Newswire via SEAPRWire.com) – Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, is acquiring […]
TOKYO, Dec 1, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (HALAVEN, […]
HONG KONG, Sep 28, 2022 – (ACN Newswire via SEAPRWire.com) – Transcenta Holding Limited (06628.HK), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of […]
TOKYO, Sep 12, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today results from a post hoc analysis of three randomized, pivotal, Phase 3 studies (EMBRACE trial/Study […]
Seoul, Korea, September 08, 2022 – (SEAPRWire) – In “the immunometabolism at the crossroads of obesity and cancer, Keystone Symposia (Sept. 5-9, 2022, Keystone, Co, USA)”, Dr. Soo-Youl Kim, Principal Scientist of the […]
HANGZHOU, Aug 19, 2022 – (ACN Newswire via SEAPRWire.com) – New Horizon Health (6606.HK), China’s leading biotechnology company for early cancer screening, announced its half-year results for the year ended […]
Ingelheim, Germany and Singapore, Jun 2, 2022 – (ACN Newswire via SEAPRWire.com) – Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement […]
TOKYO, Apr 25, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu and the Southern Tohoku General Hospital today announced the launch of a joint research project with Fujitsu Japan Limited […]
HANGZHOU, Mar 18, 2022 – (亚太商讯 via SEAPRWire.com) – 中国领先的癌症早筛生物高科技公司诺辉健康（6606.HK）今日发布2021年截至12月31日的年度业绩报告。 诺...
Oslo (Norway)/Tokyo (Japan) and Basel (Switzerland)/Mannheim (Germany), Mar 9, 2022 – (JCN Newswire via SEAPRWire.com) – NEC OncoImmunity (NOI), a subsidiary of NEC Corporation (NEC), and VAXIMM AG, a Swiss/German […]
TOKYO, Mar 7, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu and the Tokyo Medical and Dental University (TMDU) today announced a new technology that uses AI to discover new […]
TOKYO, JAPAN and WALTHAM, Mass., Dec 15, 2021 – (JCN Newswire via SEAPRWire.com) – BostonGene Corporation and NEC Corporation (TSE: 6701) today announced a strategic global partnership agreement that will […]
TOKYO, Dec 6, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that presentations on a series of abstracts highlighting updates on its in-house discovered eribulin mesylate […]
SINGAPORE – To have a more sophisticated understanding of gastric cancer, scientists here have created an intricate atlas of these cancer cells to offer more insight into how they can […]
TOKYO, Oct 19, 2021 – (JCN Newswire via SEAPRWire.com) – Aichi Cancer Center (1) and Fujitsu Limited today announced the development of an AI solution able to select effective medical […]
SINGAPORE – An orally consumed anti-cancer drug known as Bexarotene offers new hope to patients with triple-negative breast cancer (TNBC) – an aggressive form of breast cancer that appears more […]
HANGZHOU, Aug 21, 2021 – (ACN Newswire via SEAPRWire.com) – New Horizon Health (6606.HK) (the “Company”), the first public listed cancer screening company in China, has today announced its financial […]
